State Street’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-48,349
| Closed | -$19.2K | – | 4850 |
|
|
2022
Q4 | $19.2K | Sell |
48,349
-7,000
| -13% | -$2.78K | ﹤0.01% | 4735 |
|
|
2022
Q3 | $43K | Hold |
55,349
| – | – | ﹤0.01% | 4686 |
|
|
2022
Q2 | $159K | Sell |
55,349
-262,942
| -83% | -$755K | ﹤0.01% | 4310 |
|
|
2022
Q1 | $2M | Buy |
318,291
+24,009
| +8% | +$151K | ﹤0.01% | 3564 |
|
|
2021
Q4 | $3.28M | Buy |
294,282
+27,047
| +10% | +$301K | ﹤0.01% | 3450 |
|
|
2021
Q3 | $4.36M | Buy |
267,235
+31,171
| +13% | +$509K | ﹤0.01% | 3311 |
|
|
2021
Q2 | $4.37M | Buy |
236,064
+152,435
| +182% | +$2.82M | ﹤0.01% | 3312 |
|
|
2021
Q1 | $1.26M | Buy |
83,629
+16,575
| +25% | +$250K | ﹤0.01% | 3576 |
|
|
2020
Q4 | $2.17M | Buy |
+67,054
| New | +$2.17M | ﹤0.01% | 3335 |
|